SANUWAVE Health, Inc. (SNWV) Financial Statements (2024 and earlier)

Company Profile

Business Address 3360 MARTIN FARM RD
SUWANEE, GA 30024
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3321061,1531,1121,484313
Cash and cash equivalents3321061,1531,1121,484313
Receivables2,8182,9694,0292,4031,7491,730
Inventory, net of allowances, customer advances and progress billings9001,0718681,4139251,001
Inventory9001,0718681,4139251,001
Deferred costs      
Other undisclosed current assets2,0513715701,9351,181365
Total current assets:6,1014,5176,6206,8635,3393,409
Noncurrent Assets
Property, plant and equipment1,050758750673535315
Intangible assets, net (including goodwill)12,04612,22212,39712,57312,74912,925
Goodwill7,2607,2607,2607,2607,2607,260
Intangible assets, net (excluding goodwill)4,7864,9625,1375,3135,4895,665
Other noncurrent assets   106  106
Other undisclosed noncurrent assets      259
Total noncurrent assets:13,09612,98013,25313,24613,28413,605
TOTAL ASSETS:19,19717,49719,87320,10918,62317,014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,21013,81412,91216,93520,84718,307
Interest and dividends payable3,9883,6003,072
Employee-related liabilities3,7924,2643,623
Accounts payable4,8595,2644,4005,0557,0836,696
Accrued liabilities6,3518,5508,5124,1005,9004,916
Deferred revenue6762602496458
Debt17,59931,94931,12921,94724,09124,664
Due to related parties7,614 4,485  
Other liabilities1,1082552913010758
Other undisclosed current liabilities49,29316,95715,7958,8196,19010,144
Total current liabilities:79,27770,65160,18752,46551,29953,231
Noncurrent Liabilities
Long-term debt and lease obligation     761807
Long-term debt, excluding current maturities     761807
Liabilities, other than long-term debt243253258233323331
Deferred revenue215225230205295303
Deferred income tax liabilities282828282828
Other undisclosed noncurrent liabilities5153844382634034
Total noncurrent liabilities:7586376964961,1241,172
Total liabilities:80,03571,28860,88352,96152,42354,403
Equity
Equity, attributable to parent(60,838)(53,791)(41,010)(32,852)(33,800)(37,389)
Common stock562556549549529517
Additional paid in capital153,264153,046152,750152,750151,409150,533
Accumulated other comprehensive loss(80)(71)(67)(67)(67)(67)
Accumulated deficit(214,584)(207,322)(194,242)(186,084)(185,671)(188,372)
Total equity:(60,838)(53,791)(41,010)(32,852)(33,800)(37,389)
TOTAL LIABILITIES AND EQUITY:19,19717,49719,87320,10918,62317,014

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues4,6753,7755,5004,1663,8823,195
Cost of revenue(1,202)(1,262)(1,741)(606)(1,096)(889)
Gross profit:3,4732,5133,7593,5602,7862,306
Operating expenses(2,542)(4,491)(7,465)(5,400)(4,854)(3,644)
Operating income (loss):931(1,978)(3,706)(1,840)(2,068)(1,338)
Nonoperating income (expense)(8,193)(11,102)(4,450)1,4284,772(3,086)
Other nonoperating income (expense)(8,193)(11,102)(4,450)1,4274,770(3,085)
Interest and debt expense  (766)(121)(3,826)(3,093)(3,132)
Loss from continuing operations before income taxes:(7,262)(13,846)(8,277)(4,238)(389)(7,556)
Other undisclosed loss from continuing operations   (2)   
Loss from continuing operations:(7,262)(13,846)(8,279)(4,238)(389)(7,556)
Loss before gain (loss) on sale of properties:(4,238)(389)(7,556)
Other undisclosed net income (loss)  766(297)3,8253,0913,133
Net income (loss):(7,262)(13,080)(8,576)(413)2,702(4,423)
Other undisclosed net income attributable to parent   418   
Net income (loss) available to common stockholders, diluted:(7,262)(13,080)(8,158)(413)2,702(4,423)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(7,262)(13,080)(8,576)(413)2,702(4,423)
Comprehensive income (loss):(7,262)(13,080)(8,576)(413)2,702(4,423)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(9)(4)424   
Comprehensive income (loss), net of tax, attributable to parent:(7,271)(13,084)(8,152)(413)2,702(4,423)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: